GD Hospital & Diabetes Institute

Recent papers from GD Hospital & Diabetes Institute

1. Early Initiation of Sodium–Glucose Cotransporter-2 Inhibitor-Based Fixed-Dose Combinations in Type 2 Diabetes — an Indian Expert ConsensusClinical Diabetology · 2026
2. Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical ClaimsDiabetes Obesity and Metabolism · 2026
3. Knowledge of hypertension and understanding of home blood pressure monitoring among hypertensive patients in India: results from the GRAND StudyHypertension Research · 2026
4. Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta‐AnalysisClinical Obesity · 2026
5. Expert Consensus on Obesity Management Protocols – A Joint Position Statement by Obesity and Metabolic Surgery Society of India (OSSI) and Endocrine Society of India (ESI)Obesity Surgery · 2026
6. Aesthetic Gynecology – A ReviewIndian Journal of Perinatology and Reproductive Biology · 2026
7. Short‐Term HbA1c Non‐Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic InterchangeabilityDiabetes Obesity and Metabolism · 2026
8. Nutritional Considerations for Glucagon-Like Peptide-Based Therapies: An Asian Indian Consensus RecommendationObesity Pillars · 2026
9. GCK-MODY With Concurrent Islet Autoimmunity in a Child With Mild Stable Hyperglycemia: A Case ReportAACE Endocrinology and Diabetes · 2026
10. Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in IndiaBMC Endocrine Disorders · 2026
11. Mobile health applications for type 2 diabetes remission and weight management: A position statement on efficacy, regulation, and ethical implementationInternational Journal of Diabetes and Technology · 2026
12. The Mitochondrial-Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic Targets.2026
13. Gestational diabetes mellitus: Bridging research gaps through a translational frameworkAnnals of Medical Science and Research · 2026
14. Ethical and Legal Implications for the Use of Artificial Intelligence and Telemedicine in Healthcare in India: The Past, Present, and Future DirectionsInternational Journal of Diabetes and Technology · 2026
15. Commentary on: “Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity”Arthritis & Rheumatology · 2026
16. PS5-10-28: A Survivor-Led Patient Navigation Model to Improve Breast Cancer Treatment Adherence in India: Results from a Pilot ProjectClinical Cancer Research · 2026
17. Efficacy and safety of fixed-dose dapagliflozin–pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trialDiabetology & Metabolic Syndrome · 2026
18. Occupational Stress Among Nursing Staff Working at a Tertiary Care Hospital: A Snapshot of Rural Medical College of West Bengal, IndiaInternational Journal of Medicine and Health Development · 2025
19. Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD , and Stage 3 chronic kidney disease: A 12‐month observational studyDiabetes Obesity and Metabolism · 2025
20. Analysis of risk factors and predictive modelling of biomarkers in subclinical hypothyroidism and implications for levothyroxine therapy in disease managementScientific Reports · 2025